Vogenx, Inc. SEC filings VOGX

Vogenx, Inc. has 35 filings in SEC EDGAR's recent list, going back to Jan 7, 2026. The latest quarterly report (Form 10-Q) was filed on Sep 17, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 6, 2026 (results of operations). The company's fiscal year ends on December 31.

Form Description Filed Period
4 Insider transaction Oct 6, 2026 Oct 2, 2026
4 Insider transaction Oct 6, 2026 Oct 2, 2026
4 Insider transaction Oct 6, 2026 Oct 2, 2026
4 Insider transaction Oct 6, 2026 Oct 2, 2026
4 Insider transaction Oct 6, 2026 Oct 2, 2026
4 Insider transaction Oct 6, 2026 Oct 2, 2026
3 Initial insider ownership Sep 28, 2026 Sep 21, 2026
SCHEDULE 13G Ownership over 5% (passive) Sep 8, 2026 —
4 Insider transaction Aug 13, 2026 Aug 13, 2026
4 Insider transaction Aug 13, 2026 Aug 13, 2026
3 Initial insider ownership Aug 11, 2026 Aug 11, 2026
3 Initial insider ownership Aug 11, 2026 Aug 11, 2026
3 Initial insider ownership Aug 11, 2026 Aug 11, 2026
3 Initial insider ownership Aug 11, 2026 Aug 11, 2026
3 Initial insider ownership Aug 11, 2026 Aug 11, 2026
3 Initial insider ownership Aug 11, 2026 Aug 11, 2026
3 Initial insider ownership Aug 11, 2026 Aug 11, 2026

Showing 17 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
VOGX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Raleigh, NC
SEC filer status
, Emerging growth company
SEC CIK
1903784

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.